Several transgenic mouse models exhibit increased ROS production, hypertension and vascular remodeling in response to ANGII, including Nox1−/− mice [1], Sod1−/− mice [169] and mice with an inducible Nox4 deletion [170]. The gene discussed is AGT; the disease is hypertensive disorder.